¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"reducing end"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • end-to-end anastomosis
    ³¡³¡¿¬°á(¼ú), ´Ü´Ü¿¬°á(¼ú)
  • end-to-end occlusion
    ³¡³¡¸Â¹°¸², ´Ü´Ü±³ÇÕ
  • reducing agent
    ȯ¿øÁ¦, ȯ¿ø½Ã¾à
  • reducing artifact
    °¨¼ÒÀΰø¹°
  • reducing enzyme
    ȯ¿øÈ¿¼Ò
  • reducing factor
    ȯ¿øÀÎÀÚ
  • reducing substance
    ȯ¿ø¹°Áú
  • reducing sugar
    ȯ¿ø´ç
  • double-end graft
    ¾ç³¡À̽Ä, ½Ö´ÜÀ̽Ä
  • end
    ³¡, Á¾¸», ¸»´Ü
  • end apparatus
    Á¾¸»ÀåÄ¡
  • end artery
    ³¡µ¿¸Æ
  • end group
    ¸»´Ü±â
  • end organ
    Á¾¸»±â°ü
  • end organ deafness
    Á¾¸»±â°ü³­Ã»
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reducing sugar
    ȯ¿ø´ç
  • end organ
    Á¾¸»±â°ü
  • end product
    ÃÖÁ¾»ê¹°
  • positive end expiratory pressure
    ³¯¼û³¡¾ç¾Ð, È£±â¸»¾ç¾Ð
  • end-diastolic volume
    È®Àå±â¸»¿ëÀû
  • end-systolic volume
    ¼öÃà±â¸»¿ëÀû
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • end to end anastomosis
    ³¡³¡¿¬°á(¼ú), ´Ü´Ü¿¬°á(¼ú)
  • end-to-end occlusion
    ³¡³¡¹°¸², ´Ü´Ü±³ÇÕ
  • reducing agent
    ȯ¿øÁ¦, ȯ¿ø½Ã¾à
  • reducing artifact
    °¨¼ÒÀΰø¹°
  • reducing atmosphere
    ȯ¿ø´ë±â
  • reducing enzyme
    ȯ¿øÈ¿¼Ò
  • reducing factor
    ȯ¿øÀÎÀÚ
  • reducing substance
    ȯ¿ø¹°Áú
  • reducing sugar
    ȯ¿ø´ç
  • acromial end
    ºÀ¿ì¸®³¡
  • apical end
    ²ÀÁö³¡
  • end apparatus
    Á¾¸»ÀåÄ¡
  • end artery
    ³¡µ¿¸Æ
  • end to side anastomosis
    ³¡¿·¿¬°á(¼ú), ´ÜÃø¿¬°á(¼ú)
  • Krause¡¯s end bulb
    Å©¶ó¿ìÁ¦³¡¸Á¿ï
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Kerry reducing substance test
    Äɸ®È¯¿ø¹°Áú½ÃÇè
  • pressure reducing valve
    °¨¾Ð¹ëºê.
  • reducing agent
    ȯ¿øÁ¦(ü½êªð¥), ȯ¿ø½Ã¾à.
  • reducing atmosphere
    ȯ¿ø(¼º) ´ë±â.
  • reducing diet
    üÁß°¨¼Ò½ÄÀÌ(ô÷ñìÊõá´ãÝìÈ).
  • reducing diet
    üÁß°¨¼Ò½ÄÀÌ(ô÷ñìÊõá´ãÝìÈ)
  • reducing enzyme
    ȯ¿øÈ¿¼Ò(ü½êªý£áÈ).
  • reducing factor
    ȯ¿øÀÎÀÚ.
  • reducing substances
    ȯ¿ø¹°Áú
  • reducing sugar
    ȯ¿ø´ç(ü½êªÓØ).
  • reducing valve
    °¨¾Ð¹ëºê, °¨¾ÐÆÇ(Êõäâ÷û).
  • Krause s end bulbs
    Å©¶ó¿ìÁ¦Á¾¸»±¸.
  • Krauses end bulb
    Å©¶ó¿ìÁ¦Á¾¸»±¸
  • MEPP=>miniature end plate potential
    ¹Ì¼¼Á¾ÆÇÀü¾Ð
  • MEPP=£¾miniature end plate potential
    ¹Ì¼¼Á¾ÆÇÀüÀ§.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • end-to-end anastomosis
    ´Ü´Ü¹®ÇÕ¼ú
  • end-to-end anastomosis
    ´Ü´Ü¹®ÇÕ¼ú.
  • end-to-end bite =e. occlusion
    ´Ü´Ü±³ÇÕ.
  • end-to-end implantation
    ´Ü´Ü»ðÀÔ¼ú
  • pressure reducing valve
    °¨¾Ð¹ëºê.
  • reducing agent
    ȯ¿øÁ¦(ü½êªð¥), ȯ¿ø½Ã¾à.
  • reducing atmosphere
    ȯ¿ø(¼º) ´ë±â.
  • reducing diet
    üÁß°¨¼Ò½ÄÀÌ(ô÷ñìÊõá´ãÝìÈ).
  • reducing diet
    üÁß°¨¼Ò½ÄÀÌ(ô÷ñìÊõá´ãÝìÈ)
  • reducing enzyme
    ȯ¿øÈ¿¼Ò(ü½êªý£áÈ).
  • reducing factor
    ȯ¿øÀÎÀÚ.
  • reducing substances
    ȯ¿ø¹°Áú
  • reducing sugar
    ȯ¿ø´ç(ü½êªÓØ).
  • reducing valve
    °¨¾Ð¹ëºê, °¨¾ÐÆÇ(Êõäâ÷û).
  • acromial end
    ºÀ¿ì¸®³¡
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Sternal end
    º¹À峡
    [¿¾ ¿ë¾î] Èä°ñ´Ü
  • Acromial end
    ºÀ¿ì¸®³¡
    [¿¾ ¿ë¾î] °ßºÀ´Ü
  • End piece
    ³¡ºÎºÐ
    [¿¾ ¿ë¾î] ¸»´ÜºÎ
  • End piece
    ³¡ºÎºÐ
    [¿¾ ¿ë¾î] Á¾¸»ºÎ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • apical end
    ÷´ÜºÎ
  • end group spine
    ±ê³¡°¡½Ã
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reducing end
    ȯ¿ø¼º Á¾´Ü(ü½êªàõðûÓ®)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ferredoxin reducing substance
    Æä¸®µ¶½Å ȯ¿ø ¹°Áú(ü½êªÚªòõ)
  • reducing agent
    ȯ¿ø ½Ã¾à(ü½êªãËå·)
  • reducing atmosphere
    ȯ¿ø¼º ´ë±â(ü½êªàõÓÞѨ)
  • reducing equivalent
    ȯ¿ø ´ç·®(ü½êªÓ×Õá)
  • reducing power
    ȯ¿ø·Â(ü½êªÕô)
  • reducing sugar
    ȯ¿ø´ç(ü½êªÓØ)
  • advanced glycosylation end product
    ÁøÇà ´çÈ­Á¾»ê¹°(òäú¼ÓØûùðûß§Úª)
  • blunt end ligation
    µÐ´Ü¿¬°á(ÔïÓ®Ö§Ì¿)
  • blunt end
    µÐ´Ü(ÔïÓ®)
  • capped 5'-end
    ĸ °áÇÕ(Ì¿ùê)-5'-Á¾´Ü(ðûÓ®)
  • CCA-end
    CCA Á¾´Ü(ðûÓ®)
  • cohesive end
    Á¡ÂøÁ¾´Ü(ïÄó·ðûÓ®)
  • cohesive end ligation
    Á¡ÂøÁ¾´Ü°áÂû(ïÄó·ðûӮ̿óÎ)
  • dead-end complex
    Á¾¸»º¹ÇÕü(ðûØÇÜÜùêô÷)
  • end absorption
    ³¡ÆÄÀå(÷îíþ) Èí¼ö(ýåâ¥)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • end artery
    Á¾µ¿¸Æ
  • hair on end pattern
    °ïµÎ¼±¸ð¹ßÇüÅÂ
  • upper end
    »ó¿¬
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
JVP [POMD P 49 - 52]
  1) Jugular Vein Pressure
  2) Jugular Venous Pulse
...
EE embryo extract; end-to-end; end expiration; energy expenditure; Enterobacteriaceae enrichment [broth...
FRS Fellow of the Royal Society; ferredoxin-reducing substance; first rank symptom; furosemide
RS radioscaphoid; random sample; rating schedule; Raynaud syndrome; recipient's serum; rectal sinus; re...
TR recovery time; rectal temperature; repetition time; residual tuberculin; terminal repeat; tetrazoliu...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SRB Sulfate Reducing Bacteria
SRB Sulphate-reducing bacteria
EEA End-to-End Anastomosis
TUNEL 5-triphosphate (dUTP)-biotin nick end-labeling
beta-END Beta-Endorphin
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • end to end relationship
    Àý´Ü¸é°ú Àý´Ü¸é °ü°è
  • end-to-end
    ³¡°ú ³¡ÀÌ Á¢ÇÑ, öÀúÈ÷, »ô»ôÀÌ
  • end-to-end bite
    ´Ü´Ü ±³ÇÕ
    µ¿ÀǾî=end-to-end occlusion.
  • end-to-end suture
    Àý´Ü´ë Àý´Ü ºÀÇÕ
  • non-reducing
    ºñÁ¤º¹
  • non-reducing disc status
    ºñÁ¤º¹¼º °üÀý¿øÆÇ »óÅÂ
  • reducing agent
    ȯ¿øÁ¦, ȯ¿ø ¹°Áú
  • reducing disc displacement
    Á¤º¹¼º °üÀý ¿øÆÇ º¯À§
  • reducing flux
    ȯ¿ø À¶Á¦
  • advanced glycosylation end products
    ÁøÇ༺ ´çÈ­ Á¾¸» »ý¼º¹°
  • central end
    Á᫐ ¸»´Ü
  • end apparatus
    Á¾¸» ÀåÄ¡
  • end feel
    Á¾¸»°¨, Á¾¸» °¨°¢
  • end path
    Á¾·Î
  • end-expiration
    È£Èí °áÇ٠ȣ±â ¸»±â
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
end-to-end bite An occlusion in which the anterior teeth of both jaws meet along their incisal edges when the teeth are in centric occlusion.
Synonym: edge-to-edge bite, end-to-end bite, end-to-end occlusion.
(05 Mar 2000)
end-to-end occlusion An occlusion in which the anterior teeth of both jaws meet along their incisal edges when the teeth are in centric occlusion.
Synonym: edge-to-edge bite, end-to-end bite, end-to-end occlusion.
(05 Mar 2000)
reducing From Reduce.
<chemistry> Reducing furnace, a furnace for reducing ores. Reducing pipe fitting, a pipe fitting, as a coupling, an elbow, a tee, etc, for connecting a large pipe with a smaller one. Reducing valve, a device for automatically maintaining a diminished pressure of steam, air, gas, etc, in a pipe, or other receiver, which is fed from a boiler or pipe in which the pressure is higher than is desired in the receiver.
Source: Websters Dictionary
(01 Mar 1998)
reducing agent A molecule that donates an electron in an oxidation-reduction reaction.
(09 Oct 1997)
reducing agents Materials that add an electron to an element or compound, that is, decrease the positiveness of its valence.
(12 Dec 1998)
reducing diet A diet in which caloric expenditure is greater than caloric intake.
(05 Mar 2000)
reducing enzyme <enzyme> An enzyme that catalyses a reduction; since all enzymes catalyze reactions in either direction, any reductase can, under the proper conditions, behave as an oxidase and vice versa, hence the term oxidoreductase. For individual reductase's, see the specific names.
Synonym: reducing enzyme.
(05 Mar 2000)
reducing sugar A sugar, such as glucose in the urine, that has the property of reducing various inorganic ions, notably cupric ion to cuprous ion.
(05 Mar 2000)
reducing valve A valve designed to lower the pressure of a gas coming from a cylinder containing compressed gas under high pressure.
(05 Mar 2000)
coenzyme F(420) reducing hydrogenase <enzyme> From methanobacterium thermoautotrophicum
Registry number: EC 1.12.-
Synonym: f420-reducing hydrogenase, 8-hydroxy-5-deazaflavin-reducing hydrogenase, cof(420) reducing hydrogenase, coenzyme f420 hydrogenase
(26 Jun 1999)
NADP-reducing hydrogenase <enzyme> Operon from desulfovibrio contains 4 genes: hnda, hndb, hndc and hndd; does not reduce nad; genbank u07229
Registry number: EC 1.12.1.-
Synonym: hnd gene product, hndabcd gene product
(26 Jun 1999)
NAD(P)-reducing nickel hydrogenase <enzyme> From cyanobacterium, synechocystis; genbank x97610
Registry number: EC 1.12.1.-
(26 Jun 1999)
sulfur-reducing bacteria A group of gram-negative, anaerobic bacteria that is able to oxidise acetate completely to carbon dioxide using elemental sulfur as the electron acceptor.
(12 Dec 1998)
sulphate-reducing bacterium <microbiology> A prokaryote which is able to reduce sulphate SO4 (as a terminal electron acceptor) using electrons donated from organic acids, fatty acids, alcohols or hydrogen (electron donors).
(19 Jan 1998)
acromial end of clavicle The flattened lateral end of the clavicle that articulates with the acromion and is anchored to the coracoid process by the conoid and trapezoid ligaments.
Synonym: extremitas acromialis claviculae, acromial end of clavicle.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reducing
    (°¨½Ä.¾àÁ¦ µî¿¡ ÀÇÇÑ)üÁß°¨¼Ò¹ý;¸ö ¾ßÀ§´Â ¹ý
  • reducing agent
    ȯ¿øÁ¦
  • reducing glass
    Ãà¼Ò·»Áî
  • by-end
    À̱âÀûÀÎ µ¿±â
  • end
    ³¡,¸ñÀû,°á¸»
  • to the end
    ³¡±îÁö
  • END
    European Nuclear Disarmament
  • East End
    ·±´ø µ¿Á· ³¡(ÀÌÀüÀÇ ºó¹Î°¡)
  • Land's End
    ¿µ±¹ Cornwall ÁÖ ¼­´ÜÀÇ ²É
  • book end
    ºÏ¿£µå(Ã¥²ÉÀÌÀÇ ÀÏÁ¾)
  • butt end
    ±½ÀºÂÊÀdz¡;±×·çÅͱâ;³²Àº ºÎºÐ(Á¶°¢)
  • closed-end
    (ÅõÀÚ ½ÅŹÀÌ)ÀÚº»¾× °íÁ¤ÀÎ;Æó¼â½ÄÀÎ;(´ãº¸°¡)´ëºÎ ±Ý¾×À» °íÁ¤½ÃŲ
  • closed-end bond fund
    Æó¼âÇü ä±Ç ÆÝµå
  • closed-end investment company
    Æó¼âÇü ÅõÀÚ ½ÅŹ ȸ»ç
  • dead end
    ¸·´Ù¸¥ µ¥
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á